Celldex Therapeutics (CLDX) perks as price target raised
Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares jumped 1.7% to $9.36. After CLDX’s stock had its price target raised by Oppenheimer from $10.00 to $13.00 in a research report released on Feb. 26. Oppenheimer currently has an outperform rating on the stock. Share volume was 1.4 million, compared to an all-day average of 1.3 million
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here